Search research articles
Contact Us
Filters
Showing results (261-270 of 457) with videos related to
Page
of 46
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
April 16, 2020
Real-World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated With Inotuzumab Ozogamicin
Talha Badar, Aniko Szabo, Martha Wadleigh, et al.
Transplantation and Cellular Therapy
|
August 18, 2024
Surrogates of Endothelial Injury Predict Survival After Post-transplant Cyclophosphamide
Anmol Baranwal, Kimberly J Langer, Mohamed A Kharfan-Dabaja, et al.
American Journal of Hematology
|
September 20, 2018
A novel predictive model of outcome in acute myeloid leukemia without favorable karyotype based on treatment strategy, karyotype and FLT3-ITD mutational status
Kebede H Begna, Walid Ali, Naseema Gangat, et al.
Leukemia & Lymphoma
|
October 21, 2010
Autologous stem cell transplant for immunoglobulin light chain amyloidosis: a status report
Morie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
Blood Cancer Journal
|
June 17, 2020
A population-based study of chronic neutrophilic leukemia in the United States
Gordon J Ruan, Caleb J Smith, Courtney Day, et al.
Haematologica
|
January 26, 2013
The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trial
David I Marks, Anthony V Moorman, Lucy Chilton, et al.
Transplantation
|
October 8, 2020
Long-term Outcomes of Sequential Hematopoietic Stem Cell Transplantation and Kidney Transplantation: Single-center Experience
Carla Leal Moreira, M Hasib Sidiqi, Francis K Buadi, et al.
Blood Cancer Journal
|
February 20, 2024
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)
Talha Badar, Ahmad Nanaa, Ehab Atallah, et al.
Blood Cancer Journal
|
October 7, 2025
Outcomes of older patients with TP53-mutated myeloid neoplasms
Omer Jamy, Mobachir El Kettani, Kashish Shah, et al.
Haematologica
|
March 28, 2024
Cladribine plus cytarabine plus venetoclax in acute myeloid leukemia relapsed or refractory to venetoclax plus hypomethylating agent
Nickolas Steinauer, Kristen McCullough, Aref Al-Kali, et al.
Page
of 46
Search research articles
Search
Showing results (261-270 of 457) with videos related to
Sort By:
Page
of 46
Clinical Lymphoma, Myeloma & Leukemia
|
April 16, 2020
Real-World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated With Inotuzumab Ozogamicin
Talha Badar, Aniko Szabo, Martha Wadleigh, et al.
Transplantation and Cellular Therapy
|
August 18, 2024
Surrogates of Endothelial Injury Predict Survival After Post-transplant Cyclophosphamide
Anmol Baranwal, Kimberly J Langer, Mohamed A Kharfan-Dabaja, et al.
American Journal of Hematology
|
September 20, 2018
A novel predictive model of outcome in acute myeloid leukemia without favorable karyotype based on treatment strategy, karyotype and FLT3-ITD mutational status
Kebede H Begna, Walid Ali, Naseema Gangat, et al.
Leukemia & Lymphoma
|
October 21, 2010
Autologous stem cell transplant for immunoglobulin light chain amyloidosis: a status report
Morie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
Blood Cancer Journal
|
June 17, 2020
A population-based study of chronic neutrophilic leukemia in the United States
Gordon J Ruan, Caleb J Smith, Courtney Day, et al.
Haematologica
|
January 26, 2013
The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trial
David I Marks, Anthony V Moorman, Lucy Chilton, et al.
Transplantation
|
October 8, 2020
Long-term Outcomes of Sequential Hematopoietic Stem Cell Transplantation and Kidney Transplantation: Single-center Experience
Carla Leal Moreira, M Hasib Sidiqi, Francis K Buadi, et al.
Blood Cancer Journal
|
February 20, 2024
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)
Talha Badar, Ahmad Nanaa, Ehab Atallah, et al.
Blood Cancer Journal
|
October 7, 2025
Outcomes of older patients with TP53-mutated myeloid neoplasms
Omer Jamy, Mobachir El Kettani, Kashish Shah, et al.
Haematologica
|
March 28, 2024
Cladribine plus cytarabine plus venetoclax in acute myeloid leukemia relapsed or refractory to venetoclax plus hypomethylating agent
Nickolas Steinauer, Kristen McCullough, Aref Al-Kali, et al.
Page
of 46